Gale, Jeremy D.
161  Ergebnisse:
Personensuche X
?
 
?
2

Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe U..:

Sandborn, William J. ; Danese, Silvio ; Leszczyszyn, Jaroslaw...
Clinical Gastroenterology and Hepatology.  21 (2023)  10 - p. 2616-2628.e7 , 2023
 
?
6

Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates e..:

Tehlirian, Christopher ; Singh, Ravi Shankar P. ; Pradhan, Vivek...
Journal of the American Academy of Dermatology.  87 (2022)  2 - p. 333-342 , 2022
 
?
 
?
 
?
10

A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ran..:

Gale, Jeremy D. ; Berger, Brian ; Gilbert, Steven...
Investigative Opthalmology & Visual Science.  59 (2018)  6 - p. 2659 , 2018
 
?
11

A Placebo-controlled Study of PF-06473871 (Anti-Connective ..:

Gale, Jeremy D. ; Jensen, Jeff ; Berman, Gabe...
Plastic and Reconstructive Surgery - Global Open.  6 (2018)  9 - p. e1861 , 2018
 
?
 
1-15